Chlorhexidine Gluconate (CHG) Applicators, Procedural
ID: MN-2407-39Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/e6bd5084f3d44b45915b65bb96e1da03/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking to establish a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Procedural, intended for use by Military Treatment Facilities (MTFs) across various branches of the U.S. military. Vendors interested in participating must submit a QSL Package Worksheet that demonstrates compliance with stringent requirements, including TAA compliance, sterility, and FDA regulations, as well as provide detailed product specifications and documentation. The estimated annual sales volume for these products is approximately $812,276, based on historical usage data, with the QSL expected to be finalized by February 7, 2025. Interested vendors must ensure their submissions are received by January 9, 2025, and can direct inquiries to Ms. Andrea Honesto at andrea.l.honesto.ctr@health.mil or Mr. David Sheaffer at david.v.sheaffer.ctr@mail.mil.

    Point(s) of Contact
    Ms. Andrea L. Honesto Lead MMESO Clinical Analyst Contractor
    andrea.l.honesto.ctr@health.mil
    Mr. David Sheaffer MMESO Project Manager Contractor
    david.v.sheaffer.ctr@mail.mil
    Files
    Title
    Posted
    QSL Announcement MN-2407-39 CHLORHEXIDINE GLUCONATE (CHG) APPLICATORS PROCEDURAL.docx
    The Defense Health Agency (DHA) is seeking to create a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Procedural. This initiative serves Military Treatment Facilities (MTFs) and operational units across the U.S. military branches. The QSL, set to be established by February 7, 2025, aims to standardize products eligible for a Distribution and Pricing Agreement (DAPA) under the Defense Logistics Agency (DLA). Interested vendors must submit a QSL Package Worksheet detailing their qualifications and compliance with various regulatory requirements, including product labeling and approvals. Specifically, vendors must certify their products are TAA-compliant, non-latex, sterile, and meet FDA regulations. The estimated annual sales volume for these products is approximately $812,276, based on historical usage data. Vendors are advised to confirm their submissions are received and to respond by the specified deadline of January 9, 2025, to participate in the procurement process. The selection process will be conducted by a panel to determine compliance with the QSL requirements, ensuring safety and efficacy for military health applications.
    QSL Package Worksheet MN-2407-39 CHLORHEXIDINE GLUCONATE (CHG) APPLICATORS PROCEDURAL.xlsx
    The document outlines requirements for vendors to qualify for the Qualified Suppliers List (QSL) related to the provision of Chlorhexidine Gluconate (CHG) applicators for the Department of Defense (DoD) Medical/Surgical Prime Vendor Program. Vendors must possess a DAPA number or be in the process of obtaining one, as well as maintain an active status in the System for Award Management (SAM). Specific product requirements include providing detailed specifications for various CHG applicators, including part numbers, packaging details, and proof of compliance with FDA regulations. Vendors are instructed to submit comprehensive documentation demonstrating their products meet stringent criteria, such as sterility, labeling, and safety data sheets. Compliance with regulations regarding natural rubber latex is also emphasized. The process is structured to ensure that only qualified vendors are considered, reinforcing the importance of thorough documentation and adherence to quality standards within government procurement processes.
    Lifecycle
    Title
    Type
    Chlorhexidine Gluconate (CHG) Applicators, Procedural
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Specimen Container Peel Pack
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Vaginal Specula Disposable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    Skin Staplers
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Staplers, with a presolicitation notice expected to be released on or about February 9, 2025. This initiative aims to solicit information and products for evaluation, focusing on sterile, single patient use skin staplers designed for external skin closure, while excluding reloadable, reprocessed, absorbable, or rotating head staplers. The selected products must comply with the Trade Agreements Act (TAA) and be manufactured in compliant countries, with all vendors required to have a Distribution and Pricing Agreement (DAPA) and an active account in the System for Award Management (SAM). For further details, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or refer to the DLA website for additional information regarding the MSPV program.
    Cricothyrotomy Kits
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cricothyrotomy Kits, with a presolicitation notice expected to be released on or about December 5, 2024. The procurement aims to identify vendors capable of supplying single-use emergent surgical cricothyrotomy kits that meet specific technical requirements, including a cuffed and flanged airway and various surgical instruments, while ensuring compliance with the Trade Agreements Act (TAA). These kits are critical for emergency medical procedures, emphasizing the importance of having reliable and standardized medical supplies available for military personnel. Interested vendors must ensure they have an active account in the System for Award Management (SAM) and a Distribution and Pricing Agreement (DAPA) in place, with further details to be provided in the forthcoming QSL Announcement. For inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for pharmaceutical agents to be included in the Uniform Formulary (UF) as part of its pharmacy benefits program for the Military Health System (MHS). This procurement aims to establish Blanket Purchase Agreements (BPAs) and Additional Discount Programs (ADPs) for cost-effective pharmaceutical options, ensuring that the selected agents meet clinical and cost-effectiveness criteria as evaluated by the Pharmacy and Therapeutics (P&T) Committee. The initiative is critical for providing safe and effective medications to military beneficiaries while managing costs within the healthcare system. Interested manufacturers must submit their quotes by December 30, 2024, and can direct inquiries to Tracy Banks or Keith Marasigan via their respective emails for further information.
    Knee Sleeves, Hinged
    Active
    Dept Of Defense
    The US Department of Defense, through the Defense Health Agency and Defense Logistics Agency, intends to establish a list of qualified suppliers for knee sleeves, hinged, for potential use by the military. These sleeves are designed to stabilize and support the knee joint, providing pain relief and are intended for single use. They are made from various materials, cater to different sizes, and feature hinge support while being free from natural rubber latex. The upcoming Qualified Suppliers Listing (QSL) will streamline the procurement process for these medical supplies, and vendors will need to have certain agreements in place to be eligible. The QSL Announcement is expected in November 2024, and responses to this notice are neither required nor encouraged at this time.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Knee Sleeves, Compression
    Active
    Dept Of Defense
    The US Department of Defense intends to establish a Qualified Suppliers Listing (QSL) for knee compression sleeves, a medical device worn over the knee for support and pain relief. This listing will streamline future procurement processes for these specialized sleeves. The Defense Health Agency seeks to create a comprehensive QSL, which will form the basis of a subsequent Standardization Action and Incentive Agreement. Vendors must have existing contracts with specific medical suppliers and manufacture in Trade Agreements Act-compliant countries to be eligible. This advance notice is a precursor to the official QSL announcement, which will initiate the procurement process and outline participation requirements. Interested parties are advised to prepare, as responses will not be permitted until the official announcement.